Skip to main
GRAL

GRAIL Inc (GRAL) Stock Forecast & Price Target

GRAIL Inc (GRAL) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

GRAIL Inc has experienced significant stock appreciation of nearly 90% over the past month, driven by increased confidence in its multi-cancer early detection technology following positive data readouts from the PATHFINDER 2 study. The company's Total Addressable Market (TAM) analysis indicates a substantial opportunity in the US and UK, projected to reach approximately $3.7 billion by 2026, growing to about $4.0 billion by 2035. Furthermore, GRAIL has strategically established partnerships to enhance its market access, bolstered by over $400 million in pending funds that strengthen its balance sheet, suggesting a robust growth trajectory despite some regulatory uncertainties.

Bears say

GRAIL Inc. has faced substantial net losses since its inception and is projected to continue incurring such losses due to ongoing studies and the necessity of regulatory approvals. The company is operating under significant risks, including potential delays in reimbursement pathways, adoption challenges for its novel multi-cancer early detection test, and competitive pressures from established diagnostics firms. Additionally, the anticipated higher selling, general, and administrative (SG&A) expenses, combined with potential financing issues, may hinder GRAIL’s efforts to successfully commercialize its products and expand its market presence.

GRAIL Inc (GRAL) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of GRAIL Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About GRAIL Inc (GRAL) Forecast

Analysts have given GRAIL Inc (GRAL) a Buy based on their latest research and market trends.

According to 4 analysts, GRAIL Inc (GRAL) has a Buy consensus rating as of Feb 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $114.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $114.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

GRAIL Inc (GRAL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.